{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "KD",
  "name": "Kyndryl Holdings, Inc.",
  "url": "https://frontierpicks.com/dossiers/KD/",
  "json_url": "https://frontierpicks.com/dossiers/KD.json",
  "status": "WATCHLIST",
  "current_conviction": "LOW",
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Kyndryl's profit and signings improved in the September quarter but cash did not, leaving the shares' post-report jump ahead of the numbers; the fiscal third-quarter report, around early February 2027, settles whether the $400–500 million free-cash-flow target survives.",
  "invalidation_trigger": "A daily close below $12.94, the 2026-11-03 close before the fiscal second-quarter report, which would erase the post-report gain; a cut to the $400–500 million fiscal 2027 free-cash-flow guidance would also break the recovery case.",
  "catalyst_date": null,
  "pick": null,
  "themes": [
    "ai-enterprise-software"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Kyndryl's fiscal year ends March 31, so the quarter ended September 30, 2026 is reported as fiscal second-quarter 2027.",
    "In February 2026 Kyndryl disclosed an audit-committee review of cash management after SEC enforcement-division document requests, then reported material weaknesses in internal controls.",
    "Kyndryl was spun off from IBM in November 2021 and runs much of its legacy infrastructure-services business on long multi-year contracts."
  ],
  "source_links": [
    {
      "title": "kyndryl reports second quarter fiscal 2027 results",
      "url": "https://finviz.com/news/415217/kyndryl-reports-second-quarter-fiscal-2027-results",
      "date": "2026-11-04"
    },
    {
      "title": "Kyndryl (KD) Q2 2027 earnings review",
      "url": "https://finsee.ai/earnings/kd/2027/q2/en/",
      "date": null
    },
    {
      "title": "Kyndryl Stock Rockets as Earnings Beat, Strong Signings and Reaffirmed Outlook Ease Brutal Yearlong Slide",
      "url": "https://www.ibtimes.com.au/kyndryl-shares-surge-earnings-contract-signings-1877908",
      "date": null
    },
    {
      "title": "Kyndryl discloses ‘material weaknesses’ in delayed 10-Q",
      "url": "https://finance.yahoo.com/news/kyndryl-discloses-material-weaknesses-delayed-140510851.html",
      "date": null
    },
    {
      "title": "Kyndryl Needs Back-Half Ramp to Hit 2026 Goals, Morgan Stanley Says",
      "url": "https://www.itiger.com/news/2581016288",
      "date": null
    }
  ],
  "body_markdown": "## Current Thesis\n\nKyndryl's profit and signings improved in the September quarter, but cash did not, and the shares' jump after the report has moved ahead of the numbers. The evidence still points to the shares more likely lagging the S&P 500 than leading it over the next three months. The fiscal third-quarter report, around early February 2027, settles whether the $400–500 million fiscal 2027 free-cash-flow target survives.\n\nThe 2026-11-04 report answered half of the question the previous note posed. Adjusted pretax income rose to $150 million from $123 million a year earlier, and signings rose to $4.1 billion from $2.8 billion (company release). Free cash flow was a $34 million outflow, taking the first half to a $434 million outflow, while management reaffirmed the full-year target.\n\nThe market paid for the good half. Shares traded at $16.34 early on 2026-11-04, up more than 26% from the prior close of $12.94 (IBTimes), and closed at $16.29 on 2026-11-06. That sits just above the $16 average 12-month analyst target reported by fiscal.ai on 2026-11-05.\n\nThe narrative is accelerating: the 2026-11-04 report brought the first new financial results since 2026-08-05, and Scotiabank and Susquehanna raised targets the next day.\n\n## Bull Case\n\n- **Signings rebuilt the order book.** September-quarter signings of $4.1 billion compare with $2.8 billion a year earlier, and included 11 contracts above $50 million. Trailing-twelve-month signings reached $15.5 billion on 2026-09-30, up from $14.2 billion three months earlier (company releases, 2026-08-05 and 2026-11-04).\n- **Profit turned positive with margins higher.** Adjusted pretax income swung to $150 million from a $37 million first-quarter loss. Adjusted EBITDA (earnings before interest, tax, depreciation and amortization) margin rose to 19.1% from 17.2% a year earlier (company release, 2026-11-04).\n- **Restructuring charges are nearly finished.** Workforce charges reached $190 million in the first half against about $200 million expected for fiscal 2027. The company expects savings to begin in the second half and targets a $400–500 million annual cost run rate reduction in fiscal 2028 (company release, 2026-11-04).\n- **Expectations started low.** A tally by AlphaStreet cited by IBTimes on 2026-11-05 showed no positive analyst ratings, seven neutral and four negative. Adjusted earnings per share of $0.42 beat Benzinga's $0.38 estimate, though Investing.com's estimate was $0.41.\n\n## Bear Case\n\n- **The cash target needs a steep ramp.** Finsee calculates that the $450 million midpoint needs about $884 million of free cash flow in the second half, up 46.1% from $605 million a year earlier. Its review of the 2026-11-04 report also shows net capital spending up 64.8% to $206 million in the quarter.\n- **A similar ramp failed last year.** Morgan Stanley said in November 2025 that Kyndryl needed a back-half ramp to reach its goals. On 2026-02-09 the company cut fiscal 2026 free-cash-flow guidance to $325–375 million from about $550 million.\n- **Growth lines slowed in the quarter.** Hyperscaler-related revenue grew 27.2% to above $550 million, against 34% in the June quarter. Kyndryl Consult revenue grew 4.2%, against 10% (company releases, 2026-08-05 and 2026-11-04).\n- **Liquidity tightened and funding costs rose.** Cash fell to $1.66 billion on 2026-09-30 from $2.62 billion on 2026-03-31, against $4.06 billion of debt. On 2026-09-28 Kyndryl issued 7.80% and 7.875% notes, in part to repay 2.05% notes (company release, 2026-11-04).\n- **The governance overhang remains open.** The 2026-11-04 release still lists remediating material weaknesses as a risk, and Finsee found no update there on the Securities and Exchange Commission (SEC) review. The weaknesses disclosed earlier in 2026 involved deferred vendor payments (Yahoo Finance), which bears directly on how cash flow is read. This note could not confirm what the September-quarter Form 10-Q says on the inquiry.\n\n## Setup & Price Structure\n\nThe last close was $16.29 on 2026-11-06, up 21.9% over three months in adjusted daily closes. That is 40.8% below the 52-week high of $27.50. The close of $12.94 on 2026-11-03 (IBTimes) is the clearest reference level, because the report produced almost all of the gain since.\n\nThe crowding evidence is modest. The 14-day relative strength index, a momentum gauge often read as stretched above 70, was 67.0 on 2026-11-06. Targets bracket the price: Susquehanna's is $16, raised from $13 with a neutral rating, and Scotiabank's is $19 with a sector-perform rating (Benzinga, 2026-11-05). No earnings date falls in the next several weeks. Share repurchases slowed to $97 million in the first half from $151 million a year earlier (company release, 2026-11-04).\n\n## Catalyst Calendar (next 30 days)\n\n- **Through 2026-12-07:** No company-scheduled financial event was found. The AWS agentic modernization partnership was announced on 2026-11-05, ahead of this window (Benzinga).\n- **~2027-02-03, est.:** Fiscal third-quarter 2027 report. Last year's equivalent report came with the guidance cut on 2026-02-09. December-quarter free cash flow is the first direct test of the second-half target.\n\n## What Would Change Our Mind\n\nThe recovery case breaks if Kyndryl cuts the $400–500 million free-cash-flow target, discloses a restatement, a delayed periodic report or added material weaknesses, or receives a Wells notice from the SEC. On price, a close below $12.94 would erase the gain from the report. The shares closed under the $13.00 invalidation level in the previous note on 2026-11-03, before the results reversed the move.\n\nThe view that the shares lag would prove wrong if the December quarter shows a large free-cash-flow inflow with the target reaffirmed, and without added reliance on deferred vendor payments. Upgrades from neutral or negative analysts following that report would support the same conclusion. Outperformance of the S&P 500 through the February report would also show the call was wrong.\n\n## Correlation Notes\n\nKyndryl's move came from its own report, on a day when the Dow rallied 2.9% after the midterm elections and hyperscalers rose (Benzinga, 2026-11-04). Part of the report-day gain may therefore reflect the market. A reversal in that rally would test the shares without any change in the business.\n\nFrontierPicks' tracking of the AI enterprise software group, which includes ACN, EPAM, GLOB and GDYN, moved to accelerating on 2026-11-06 from maturing on 2026-11-01. That helps sentiment but does not decide this case, because the cash and governance questions are specific to Kyndryl. Peer strength would matter less if Kyndryl's December-quarter cash flow disappoints.",
  "first_seen": "2026-10-23",
  "last_analyzed": "2026-11-07T08:16:57+00:00",
  "last_synthesized": "2026-11-07",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}